Stockreport

GlycoMimetics Announces Plans to Initiate Breast Cancer Trial to Evaluate GMI-1359

GlycoMimetics, Inc.  (GLYC) 
Last glycomimetics, inc. earnings: 5/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.glycomimetics.com/investor-relations
PDF Proof-of-concept trial to evaluate safety and biomarkers of cancer cell mobilization in patients with hormone receptor positive metastatic br [Read more]